Newsletter | April 24, 2024

04.24.24 -- Understanding Changes In Product Liability Law

FEATURED ARTICLE

Michigan No Longer A Safe Haven For Pharmaceutical Companies?

A recent change to Michigan's product liability law could have national implications. Experts at Sidley Austin detail the changes in Michigan and explain what it could mean for pharmaceutical companies marketing products in Michigan and beyond.

INDUSTRY INSIGHTS

ePROs: How They’re Transforming Oncology Research

ePRO and eCOA are helping to overcome oncology-specific challenges in clinical research. Find out how you can make life easier for patients when it matters most.

Identify And Quantify AAV Fill States Using Analytical Ultracentrifugation

Explore how to implement analysis using SV-AUC to characterize AAV size distributions using multiple detection wavelengths to identify various fill states in AAV preparation.

The MAPPs Assay: A Useful Tool For The Assessment Of Immunogenicity

Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.

Scaling Patient Safety Through Innovation

In this podcast episode, Michael Braun-Boghos and Cheryl James share their expertise and perspectives on leveraging innovative approaches to enhance patient safety initiatives.

Put Your AAV On The Fast-Track To The Clinic

Review an innovative approach to fast-tracking AAVs through a platform approach that easily scales as the project progresses to late-stage GMP production and to market.

2023 Site Payments And Budgeting Market Trends Survey

Explore the findings from this survey of the global clinical trials market, shedding light on processes, challenges, and preferences associated with global site payments, and more.

Clinical Data Platform Considerations To Lessen CRO Reliance

Explore the crucial factors necessary to evaluate clinical data platforms, leading to more streamlined and effective management of clinical trials.

Solid Form Strategies For Increasing Oral Bioavailability

Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: